Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1073033 | 0.96 | CYP2C9 (0.44) | CYP2C9EPHX2HSD11B1 | |
| Methyl Alcohol SCHEMBL29101469 | 0.87 | CYP2C9 (0.45) | CYP2C9EPHX2HSD11B1 | |
| SCHEMBL2745869 | 0.73 | P2RX7 (0.35) | CYP2C9 | |
| SCHEMBL9215201 | 0.71 | P2RX7 (0.34) | CYP2C9 | |
| Adamantane SCHEMBL28667997 | 0.71 | CYP2C9 (0.43) | CYP2C9EPHX2 | |
| SCHEMBL4054861 | 0.67 | LMNA (0.33) | — | |
| SCHEMBL2214844 | 0.67 | CYP2C9 (0.44) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL12761 | 0.66 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL1527414 | 0.66 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 | |
| Adamantane SCHEMBL29707714 | 0.66 | CYP2C9 (0.46) | CYP2C9EPHX2HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250002617-A1 | C1 SYMMETRIC METALLOCENE CATALYSTS TAILORED FOR PRODUCTION OF VINYL-TERMINATED POLYPROPYLENE OLIGOMERS AND MACROMONOMERS | ExxonMobil Technology and Engineering Company (US) | 2025-01-02 | — | — | US | disclosed |
| EP-4396246-A1 | C1 SYMMETRIC METALLOCENE CATALYSTS TAILORED FOR PRODUCTION OF VINYL-TERMINATED POLYPROPYLENE OLIGOMERS AND MACROMONOMERS | ExxonMobil Chemical Patents Inc. (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023034889-A1 | C1 SYMMETRIC METALLOCENE CATALYSTS TAILORED FOR PRODUCTION OF VINYL-TERMINATED POLYPROPYLENE OLIGOMERS AND MACROMONOMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-03-09 | — | — | WO | disclosed |
| US-20100168077-A1 | Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof | UCB PHARMA, S.A. (BE) | 2010-07-01 | — | — | US | disclosed |
| EP-2144877-A1 | NOVEL PYRIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS THEREOF | UCB Pharma, S.A. (BE) | 2010-01-20 | — | — | EP | disclosed |
| WO-2008122378-A1 | NOVEL PYRIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS THEREOF | UCB PHARMA, S.A. (BE) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168077-A1 | Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof | CYP4B1, CYP3A4, CYP2C19 | CYP2C9 10/4885EPHX2 1314/4885HSD11B1 2689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.